CTNNB1 and cancer: Oncogenic mutations in CTNNB1, most frequently missense mutations in exon 3, have been recurrently identified in liver [6], and uterine [7] cancers, and in a small subset of non-small cell lung cancers (NSCLCs) [8–10].